Latest News and Press Releases
Want to stay updated on the latest news?
-
BROSSARD, Quebec, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the...
-
BROSSARD, Québec, 12 nov. 2020 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX: ADK) (OTCQB: DGNOF), un chef de file dans la détection précoce des...
-
BROSSARD, Quebec, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the...
-
BROSSARD, Quebec, Nov. 05, 2020 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early...
-
BROSSARD, Quebec, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues using...
-
BROSSARD, Québec, 06 oct. 2020 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX: ADK) (OTCQB: DGNOF), un chef de file dans la détection précoce des...
-
BROSSARD, Quebec, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues using...
-
BROSSARD, Québec, 28 sept. 2020 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX: ADK) (OTCQB: DGNOF), un chef de file dans la détection précoce des...
-
BROSSARD, Quebec, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through...
-
BROSSARD, Quebec, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK, OTCQB: DGNOF), a leader in early detection of critical health issues through the...